Skip to main content
IMEXHS LIMITED logo

IMEXHS LIMITED — Investor Relations & Filings

Ticker · IME ISIN · AU0000023053 ASX Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 1,057 across all filing types
Latest filing 2019-10-06 Capital/Financing Update
Country AU Australia
Listing ASX IME

About IMEXHS LIMITED

https://imexhs.com

IMEXHS LIMITED develops and provides cloud-based medical imaging software and diagnostic services. The company’s core offering includes a suite of solutions such as Picture Archiving and Communication Systems (PACS) and Radiology Information Systems (RIS), designed to streamline medical imaging workflows. Its primary platform, AQUILA, utilizes a cloud-native architecture to facilitate the storage, distribution, and viewing of medical images across various devices. IMEXHS integrates artificial intelligence and machine learning capabilities into its tools to assist in diagnostic accuracy and operational efficiency. The company employs a Software-as-a-Service (SaaS) model, offering scalable solutions for healthcare providers ranging from independent clinics to complex hospital networks. These technologies support teleradiology and remote diagnostics, focusing on improving accessibility and data management in clinical environments.

Recent filings

Filing Released Lang Actions
Appendix 3B 13 pages 296.2KB
Capital/Financing Update Classification · 100% confidence The document is titled 'Appendix 3B' and is an announcement related to the issuance of new securities, including unlisted options and shares, with detailed information about the number, class, terms, and purpose of the securities issued. It includes references to ASX rules, shareholder approvals, issue prices, and quotation applications. The content is focused on capital raising activities and compliance with stock exchange regulations regarding new securities issuance. There are no financial statements or management discussions, nor is it a report or transcript. This matches the definition of a Capital/Financing Update, which covers updates on company fundraising, financing activities, or capital structure changes.
2019-10-06 English
Appendix 3Y-Doug Lingard 2 pages 82.3KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act. It details changes in securities holdings by a company director, including direct and indirect interests, dates of changes, and nature of transactions. The document is a formal notification of insider share transactions by a director, consistent with regulatory requirements for disclosure of personal share dealings by company directors. It does not contain financial statements, earnings data, or management discussion. The document length is 4138 characters, which is typical for such notices. Therefore, this document fits the category of Director's Dealing (DIRS).
2019-10-06 English
Results of Meeting 2 pages 244.6KB
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is an announcement titled 'Results of General Meeting' for ImExHS Limited, dated 3 October 2019. It provides detailed proxy voting results for resolutions voted on at a General Meeting, including the number of proxy votes for, against, abstain, and discretionary votes. The document references compliance with Section 251AA(2) of the Corporations Act 2001, which pertains to disclosure of voting results. The content is focused on the official results of shareholder votes at a general meeting, not the meeting materials, financial reports, or management changes. The document length is 2909 characters, which is relatively short but contains substantive voting results data, not just a notice or link to a report. Therefore, it fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2019-10-02 English
Notice of General Meeting/Proxy Form 9 pages 809.7KB
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a Notice of General Meeting for ImExHS Ltd, detailing the agenda for shareholder approval to issue options to a related party, Domatorisaro Pty Limited, controlled by a non-executive director. It includes the meeting date, time, place, voting instructions, explanatory statement, and terms of the options issuance. The content focuses on shareholder meeting logistics and resolutions requiring shareholder vote, specifically related to capital raising via option issuance to a related party. This type of document is a proxy solicitation and information statement sent to shareholders to inform them and solicit votes for the meeting resolutions. It is not a financial report, earnings release, or announcement of voting results, but rather the meeting notice and explanatory materials. Therefore, the appropriate classification is Proxy Solicitation & Information Statement (PSI). The document length and detail confirm it is the actual meeting notice and explanatory statement, not just an announcement of a report.
2019-09-01 English
Appendix 4D & Half-Year Financial Statements 25 pages 2.4MB
Interim / Quarterly Report Classification · 100% confidence The document is titled 'APPENDIX 4D HALF-YEAR REPORT FOR THE PERIOD ENDED 30 JUNE 2019' and contains detailed financial statements such as consolidated statement of profit or loss, financial position, cash flows, notes to the accounts, and an auditor's review report. It includes a Directors' Report with detailed operational and financial commentary, revenue growth, strategy, and outlook. The document covers a half-year period and contains substantive financial data and analysis, not just an announcement or summary. This matches the definition of an Interim / Quarterly Report (IR). The document length is 15,000 characters, indicating it is a full report rather than a brief announcement or certification. Therefore, the correct classification is IR with high confidence. H1 2019
2019-08-26 English
IME receives FDA Clearance for Hiruko Essential in the USA 2 pages 359.3KB
Regulatory Filings Classification · 95% confidence The document is an ASX company announcement about IMEXHS receiving FDA clearance for commercialisation of its Hiruko Essential software in the USA market. It highlights regulatory approval and market entry strategy but does not contain financial statements, management discussion, or detailed financial data. The document is an announcement of a regulatory milestone and business update rather than a financial report or detailed investor presentation. It does not fit categories like Annual Report, Interim Report, Earnings Release, or Investor Presentation. It is not a report publication announcement since it is the announcement itself. The content aligns best with a general Regulatory Filing (RNS) as it is a regulatory and business update announcement without detailed financial data or report content.
2019-08-04 English

Browse filings by year

22 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.